CYP19A1 and breast cancer: Recently, not only estrogens themselves but also estrogen related enzymes have been proposed as a target of hormonal therapy, such as aromatase and aromatase inhibitor, which are used as a gold standard treatment for estrogen-dependent post-menopausal breast cancer patients [7].